Day: February 5, 2026

Austin, Texas, Feb. 05, 2026 (GLOBE NEWSWIRE) — Digital Brands Group, Inc. (“DBG” or the “Company”) (Ticker: [NASDAQ:DBGI]), a publicly traded company specializing in eCommerce and Fashion today announced that it will coordinate four campus photo shoots in the month of February, including two new universities. The two new universities include the University of Colorado and Vanderbilt University. Both shoots will highlight student athletes and members of sororities and fraternities. Additionally, we will feature iconic locations on each campus, as well as special appearances. We will also be returning to two universities where we initially launched our Name, Image, and Likeness (“NIL”) strategic initiative – the University of Alabama and the University of Mississippi. Our women’s apparel brand, AVO, will feature female student athletes...

Expected record fiscal second quarter revenue increase driven by expanding customer base and strong growth across all product categories Reader sales expected to post year-over-year growth of more than 100% in fiscal Q2, expanding installed base to drive sustained recurring cartridge revenue NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced preliminary, unaudited revenue results for the fiscal second quarter and first half 2026 ended December 31, 2025.  The Company expects to report strong revenue growth across all product categories for the three- and six-month periods ended December 31, 2025. Six-Month Period (Fiscal H1 ’26, July –...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) — via AINewsWire — Nightfood Holdings Inc. (NGTF) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio @ IBN  (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “The Hidden Revenue Drain in Hospitality—and How AI Robotics Is Finally Closing the Gap,” please visit: https://ibn.fm/Dg27D In high-traffic venues such as stadiums, convention centers, airports and other live-event locations, staffing challenges have evolved into a direct constraint on revenue generation. Ongoing labor shortages across hospitality and food service are colliding with...

BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) — Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced it awarded inducement grants on February 2, 2026 to two new employees under Bicara’s 2026 Inducement Plan as a material inducement to employment. The employees received, in the aggregate, non-qualified stock options to purchase 158,900 shares of Bicara’s common stock, par value $0.0001 per share, with an exercise price of $16.76 per share, equal to the closing price of Bicara’s common stock as reported by Nasdaq on February 2, 2026. One-fourth of the options vest on the first anniversary of the employee’s applicable start date, with the remaining options vesting in 12 equal quarterly installments thereafter,...

LAS VEGAS, Feb. 05, 2026 (GLOBE NEWSWIRE) — Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal first quarter ended December 31, 2025, before the market opens on Thursday, February 12, 2026. The Company will hold a conference call to discuss the results on Thursday, February 12, 2026, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time). The dial-in numbers are as follows:800.231.0316 (U.S.) +1.314.696.0504 (International/caller-paid) Conference Title: Live Ventures Fiscal First Quarter 2026 Earnings Conference CallPlease dial in at least 15 minutes in advance, but no sooner than 30 minutes, to ensure you are connected. To listen to the discussion after the call, please visit the “Investor Relations” page...

Amaze Brings Premium Merchandise Offerings to the Popular EDM Event in Miami this Spring NEWPORT BEACH, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”) a global leader in creator-powered commerce, announced today a collaboration with Winter Music Conference 2026 (“WMC 2026”) as their official branded merchandise partner. WMC 2026 will take place March 24-26 in Miami, Florida, and is widely known as the world’s longest running electronic music conference, bringing together artists, producers, industry executives, creators, and fans for multiple days of programming, education, networking, and live experiences. Through this collaboration, Amaze will provide official WMC 2026 merchandise and digital engagement opportunities for attendees both on site and online. Amaze’s presence at WMC...

HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that the Canadian Intellectual Property Office has issued Canadian Patent No. 3118732, titled “Treatment of Cachexia Using Fibroblast Cells and Products Thereof.” This patent strengthens FibroBiologics’ intellectual property portfolio and underscores the Company’s commitment to advancing innovative therapies for debilitating conditions like cachexia. Cachexia, a complex metabolic syndrome characterized by severe weight loss, muscle wasting, and inflammation, often accompanies chronic diseases...

Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) — HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that the University of the West of England (“UWE”) has adopted the Company’s MyoVista Insights™ platform and MyoVista® wavECG™ device as its exclusive ECG technologies to establish a Reference Center for ECG Education and Technology. Under the agreement, MyoVista Insights and the MyoVista wavECG device will be used exclusively across UWE’s cardiac and physiological science teaching programs to train the next generation of cardiac scientists. UWE is one of the UK’s largest providers of Cardiac Healthcare Science and Physiological...

Appointment Strengthens RenovoRx’s C-Suite Leadership to Support Commercial Growth of RenovoCath® MOUNTAIN VIEW, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, is pleased to announce the appointment of Mark Voll as the Company’s Chief Financial Officer, effective February 1, 2026. Mr. Voll brings more than three decades of financial leadership experience to RenovoRx, with a strong track record for guiding high-growth public companies through periods of commercial buildout and strategic development. He has served as Chief Financial Officer for multiple publicly traded technology companies where he successfully led corporate...

SAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2025 earnings release and conference call. The Company will release its fourth quarter 2025 results on Thursday, February 19, 2026 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, February 19, 2026. The call can be accessed at (800) 274-8461, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company’s website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will...